By attenuating IL-1β, IL-6, IL-8 and related chemokines, statins may weaken the inflammatory pathways that sustain tumour growth and immune evasion in cancer and strengthen the efficacy of therapeutic regimens in cancer patients. The gene discussed is CXCL8; the disease is cancer.